Indwelling Interscalene Nerve Catheters in Surgical Management of Idiopathic Adhesive Capsulitis
Primary Purpose
Frozen Shoulder
Status
Unknown status
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Interscalene block with nerve catheter
Sponsored by
About this trial
This is an interventional treatment trial for Frozen Shoulder
Eligibility Criteria
Inclusion Criteria:
- Males and Females over the age of 18 with a diagnosis of idiopathic adhesive capsulitis
- Failed conservative treatment for a minimum of 4 months
- Patient had 3 sequential office visits with no clinical improvement
Exclusion Criteria:
- Adhesive capsulitis following a surgical procedure and/or fracture
Sites / Locations
- OAD OrthopaedicsRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
No Intervention
Experimental
Arm Label
Single in interscalene block
Interscalene block with nerve catheter
Arm Description
Single indwelling interscalene block with ropivacaine 0.5% 10ml
Interscalene block with ropivacaine 0.5% 10ml and placement of an indwelling nerve catheter with ropivacaine 0.2% @5ml/hr for 24 hours
Outcomes
Primary Outcome Measures
Improvement in shoulder function as demonstrated by increased range of motion
The primary outcome measure will be an improvement in shoulder function as measured by the ASES shoulder score.
Secondary Outcome Measures
Decrease in shoulder pain
The secondary outcome measure will be a reduction in shoulder pain as measured by the VAS pain score.
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT01606332
Brief Title
Indwelling Interscalene Nerve Catheters in Surgical Management of Idiopathic Adhesive Capsulitis
Official Title
Indwelling Interscalene Nerve Catheters in Surgical Management of Idiopathic Adhesive Capsulitis
Study Type
Interventional
2. Study Status
Record Verification Date
June 2013
Overall Recruitment Status
Unknown status
Study Start Date
June 2012 (undefined)
Primary Completion Date
July 2014 (Anticipated)
Study Completion Date
July 2014 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
OAD Orthopaedics
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
In patients who undergo shoulder manipulation for idiopathic adhesive capsulitis, a postoperative indwelling analgesic pain catheter will improve patient outcomes by decreasing shoulder pain and improving range of motion compared to a single-dose interscalene block.
Detailed Description
Shoulder manipulation under anesthesia to treat idiopathic adhesive capsulitis is performed only when conservative treatment fails to remedy the condition.
It is common practice to use an interscalene nerve block as anesthesia for this surgical intervention. This randomized prospective study is designed to evaluate the effects of two different anesthesia methods on patient's post-surgical rehabilitation after manipulation. Forty patients scheduled for surgery will be entered into this study. Patients will be randomly assigned to receive a single-doseinterscalene block or a single-dose interscalene block and an indwelling nerve catheter which will provide a continuous infusion of local anesthetic. Patients with the continuous infusion of local anesthetic will receive the additional anesthesia for 24 hours. Patient's range of motion will be evaluated pre-op, intra-op and post-operatively at 10 days, 4,8,16 weeks and 6 months
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Frozen Shoulder
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
40 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Single in interscalene block
Arm Type
No Intervention
Arm Description
Single indwelling interscalene block with ropivacaine 0.5% 10ml
Arm Title
Interscalene block with nerve catheter
Arm Type
Experimental
Arm Description
Interscalene block with ropivacaine 0.5% 10ml and placement of an indwelling nerve catheter with ropivacaine 0.2% @5ml/hr for 24 hours
Intervention Type
Procedure
Intervention Name(s)
Interscalene block with nerve catheter
Intervention Description
Interscalene block with ropivacaine 0.5% 10ml and placement of an indwelling nerve catheter with ropivacaine 0.2% @5ml/hr for 24 hours
Primary Outcome Measure Information:
Title
Improvement in shoulder function as demonstrated by increased range of motion
Description
The primary outcome measure will be an improvement in shoulder function as measured by the ASES shoulder score.
Time Frame
10 days, 4, 8, 16 weeks and 6 months
Secondary Outcome Measure Information:
Title
Decrease in shoulder pain
Description
The secondary outcome measure will be a reduction in shoulder pain as measured by the VAS pain score.
Time Frame
10 days, 4, 8, 16 weeks and 6 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Males and Females over the age of 18 with a diagnosis of idiopathic adhesive capsulitis
Failed conservative treatment for a minimum of 4 months
Patient had 3 sequential office visits with no clinical improvement
Exclusion Criteria:
Adhesive capsulitis following a surgical procedure and/or fracture
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Marjorie Delaney, APN
Phone
630-225-2554
Email
marjorie.delaney@oadortho.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Aaron A Bare, MD
Organizational Affiliation
OAD Orthopaedics
Official's Role
Principal Investigator
Facility Information:
Facility Name
OAD Orthopaedics
City
Warrenville
State/Province
Illinois
ZIP/Postal Code
60555
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Marjorie L Delaney, APN
Phone
630-225-2554
Email
marjorie.delaney@oadortho.com
12. IPD Sharing Statement
Learn more about this trial
Indwelling Interscalene Nerve Catheters in Surgical Management of Idiopathic Adhesive Capsulitis
We'll reach out to this number within 24 hrs